China Active Implantable Medical Devices Market Size, Share & Trends Analysis Report By Product Type (Implantable Cardioverter Defibrillators, Transvenous Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Active Hearing Implants, Non-active/Passive Hearing Implants), By End-User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: September 01, 2026 | Author: Debashree Bora | Format:

China Active Implantable Medical Devices Market Size

The China active implantable medical devices market size was valued at USD 4.32 billion in 2025 and is projected to grow from USD 4.74 billion in 2026 to reach USD 9.88 billion by 2034, growing at a CAGR of 9.63% during the forecast period 2026–2034.

This surge is attributed to rapid healthcare advancements, a rising prevalence of chronic diseases, and increasing investment in medical technology infrastructure. Furthermore, the demand for implantable cardioverter defibrillators (ICDs), neurostimulators, and pacemakers is expected to grow exponentially, driven by urbanization, lifestyle changes, and technological innovation.

Download a Free Sample To learn more about this report.

China Active Implantable Medical Devices Market Segmentation Analysis

By Product

Implantable Cardioverter Defibrillators dominate the product segment and are expected to grow at a CAGR of 10.9% over the forecast period, driven by rising incidences of cardiac arrhythmias and sudden cardiac arrest. Innovations in leadless ICDs, MRI-compatible devices, and government subsidies fuel their adoption. Domestic players like Lepu Medical are expanding their portfolios to ensure affordable, high-quality solutions.

China Active Implantable Medical Devices Market Size By Segments

Request Customizationto receive a tailored report.

By End User

Hospitals dominate the end-user segment and are expected to grow at a CAGR of 9.9% during the forecast period. China’s significant investment in public and private hospitals under the Healthy China 2030 initiative ensures the availability of advanced medical technologies. High patient footfall in tertiary care hospitals further solidifies their position as the primary end-users.

China Active Implantable Medical Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

China Active Implantable Medical Devices Market Regional Insights

The market is characterized by regional disparities in healthcare infrastructure, urbanization trends, and targeted investments in medical technology. Key cities drive growth through innovation and accessibility.

Beijing is a leader in healthcare innovation and AIMD adoption. Institutions like Peking Union Medical College Hospital (PUMCH) pioneer advanced treatments, attracting patients nationwide. The city’s focus on AI in healthcare fosters partnerships between medtech companies and research institutions.
Shanghai’s robust healthcare infrastructure and high prevalence of chronic diseases make it a significant market for AIMDs. Companies like MicroPort Scientific Corporation, headquartered in the city, drive innovation in ICDs and neurostimulators. Shanghai’s advanced hospital networks and medical research facilities support market growth.
Guangzhou, known for its rapidly expanding healthcare services, emphasizes affordable and accessible treatments. The city’s large aging population and rising cardiac disease burden fuel the demand for pacemakers and ICDs. Partnerships with global manufacturers enhance the availability of advanced devices.
Shenzhen, as a technology hub, integrates AI and IoT into healthcare, advancing the AIMDs market. Startups and tech giants like Huawei collaborate with medical device manufacturers to develop smart solutions. Shenzhen’s innovation ecosystem accelerates market penetration.
Chengdu’s growing healthcare infrastructure and focus on improving rural healthcare access make it a promising market. Regional hospitals are adopting AIMDs for cardiovascular and neurological treatments, supported by government subsidies and training programs.

List of Key and Emerging Players in China Active Implantable Medical Devices Market

Medtronic PLC

Abbott Laboratories

Boston Scientific Corporation

Livanova PLC

Nurotron Biotechnology Co. Ltd.

Biotronik Se & Co., Kg

William Demant Holding A/S

Cochlear Limited

Sonova Holding AG

Key Industry Developments

May 2026 – Medtronic expanded its active implantable medical device portfolio in China by introducing next-generation implantable cardiac rhythm management and neuromodulation technologies, supporting the growing demand for advanced minimally invasive therapies.

March 2026 – Abbott strengthened its presence in China's active implantable medical devices market by expanding the availability of implantable cardiac pacemakers, defibrillators, and remote patient monitoring solutions to improve long-term cardiac care.

October 2025 – BIOTRONIK enhanced its implantable cardiac device portfolio in China with advanced pacemakers and implantable cardioverter-defibrillators (ICDs) featuring improved battery life, wireless connectivity, and MRI compatibility.

July 2025 – MicroPort Scientific Corporation expanded its domestically developed active implantable medical devices by introducing innovative cardiac rhythm management solutions and strengthening local manufacturing capabilities to support China's medical device self-sufficiency initiatives.

Report Scope

Segmentation

By Product Type 9

Implantable Cardioverter Defibrillators
Transvenous Implantable Cardioverter Defibrillators
Subcutaneous Implantable Cardioverter Defibrillators
Spinal Cord Stimulators
Deep Brain Stimulators
Sacral Nerve Stimulators
Vagus Nerve Stimulators
Active Hearing Implants
Non-active/Passive Hearing Implants

By End-User 4

Hospitals
Ambulatory Surgery Centers
Specialty Clinics
Others

Competitive Coverage Medtronic PLC · Abbott Laboratories · Boston Scientific Corporation · Livanova PLC · Nurotron Biotechnology Co. Ltd.

Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

How much is the China active implantable medical devices market worth?

Straits research predicts that the China active implantable medical devices market size was valued at USD 4.32 billion in 2025 and is projected to grow from USD 4.74 billion in 2026 to reach USD 9.88 billion by 2034.

At what CAGR is the China market projected to grow during the forecast period of 2026-2034?

The China market growth rate growing at a 9.63% from 2026 to 2034.

What are the key factors driving the market?

The high prevalence of cardiovascular diseases and government initiatives, is a key growth factor driving advancements in active implantable medical devices.

Which city held the highest share of the market?

Beijing holds the largest market share with its healthcare innovation and AIMD adoption.

Which segment will lead in the market by end user?

Currently, the hospital segment dominates the market, fueled by significant investment in public and private hospitals.

About the Author

Debashree Bora

Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.